dc.contributor.author | Sargin, M. | |
dc.contributor.author | Oguzhan, B. | |
dc.contributor.author | Olmez, B. | |
dc.contributor.author | Karadeniz, S. | |
dc.contributor.author | Yilmaz, T. | |
dc.date.accessioned | 2021-03-03T19:35:17Z | |
dc.date.available | 2021-03-03T19:35:17Z | |
dc.identifier.citation | Yilmaz T., Sargin M., Olmez B., Karadeniz S., Oguzhan B., "Which of the criteria is more accurate ADA(IFG100) or IDF(IFG110) for the prediction of IGT 1 and IGT2 at high risk group? The RISK Study Results III", 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, Hollanda, 18 - 21 Eylül 2007, cilt.50 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_55632b77-89bb-44cf-af7a-01551da7be6a | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/60362 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.title | Which of the criteria is more accurate ADA(IFG100) or IDF(IFG110) for the prediction of IGT 1 and IGT2 at high risk group? The RISK Study Results III | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 50 | |
dc.contributor.firstauthorID | 134204 | |